Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today.
Total revenues decreased 24% year-over-year to $2.6 billion. On a constant currency basis, revenues fell 25%.
Net income attributable to Biogen amounted to $410 million, or $2.69 per share, compared to $1.4 billion, or $8.08 per share. Adjusted net income was $813 million, or $5.34 per share.
For the full year of 2021, Biogen expects total revenue of $10.45-10.75 billion and adjusted EPS of $17.50-19.00.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report
Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results
Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a
